NASDAQ
Iovance Biotherapeutics, Inc. (IOVA) has a free cash flow growth of -27.14% as of Friday, May 29, 2026. This represents a 8368.08% decrease compared to its 12-month average of 0.33%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.